Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells
Fang Huang,1,* Jinjin Zhao,1,* Yiting Wei,1 Zhifa Wen,1 Yue Zhang,1 Xuru Wang,1 Yanfei Shen,2 Li-xin Wang,1 Ning Pan1 1Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, Jiangsu Province 210009, People’s Republic of China; 2Department of Bioengineer...
Guardado en:
Autores principales: | Huang F, Zhao J, Wei Y, Wen Z, Zhang Y, Wang X, Shen Y, Wang L, Pan N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed3d11776a4949bc8da6443b2c6962b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor Targeting Chemo- and Photodynamic Therapy Packaged in Albumin for Enhanced Anti-Tumor Efficacy
por: Zheng K, et al.
Publicado: (2020) -
The San1 Ubiquitin Ligase Avidly Recognizes Misfolded Proteins through Multiple Substrate Binding Sites
por: Rebeca Ibarra, et al.
Publicado: (2021) -
Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling
por: Anmol Sharma, et al.
Publicado: (2021) -
Current Strategies for Tumor Photodynamic Therapy Combined With Immunotherapy
por: Jianfeng Hua, et al.
Publicado: (2021) -
Nanoparticle-Assisted Sonosensitizers and Their Biomedical Applications
por: Zhao P, et al.
Publicado: (2021)